Top 4 Dating App Stocks WarrenAI Says to Watch in 2026

Investing.com -- Robinhood Markets (NASDAQ:HOOD) stock dropped 10% on Monday as investors appeared concerned about weakness in cryptocurrency markets and signs of diminishing retail trading appetite.

The sharp decline in Robinhood outpaced crypto exchange Coinbase (NASDAQ:COIN), despite the latter having greater exposure to digital assets. This divergence has fueled speculation that broader concerns about retail investor sentiment may be driving Robinhood’s selloff, particularly as speculative assets like gold, silver, and cryptocurrencies have experienced recent volatility.

Cryptocurrency prices fell approximately 7% over the weekend, which likely contributed to pressure on Robinhood, where crypto represents about 15% of assets under custody and 21% of revenue as of the third quarter.

Mizuho analyst Daniel J. O’Regan noted he’s been fielding questions about the stock’s decline. Technical factors may also be at play, as Robinhood broke below its 200-day moving average last week, accelerating its downward momentum. The stock has now reached seven-month lows and has fallen 44% from its October highs.

"Meme stocks, Silver, Crypto, Spec assets have been under pressure. Not sure how much that would impact HOOD trading volumes," he commented.

The broader pullback in speculative investments, including meme stocks and precious metals, suggests retail investors may be adopting a more cautious stance amid market uncertainty. Robinhood, which rose to prominence during the 2021 retail trading boom, remains particularly sensitive to shifts in individual investor sentiment.

Despite Monday’s decline, Mizuho’s Dan Dolev highlighted a potential positive catalyst for the company, noting Robinhood’s recent launch of a stocks and shares ISA in the UK with zero platform fees, no commissions, and a 2% cash bonus on eligible contributions made before April 2026.

Investing.com – Brazil stocks were higher after the close on Monday, as gains in the Real Estate, Consumption and Financials sectors led shares higher.

At the close in Sao Paulo, the Bovespa rose 0.40%.

The best performers of the session on the Bovespa were Direcional Engenharia SA (BVMF:DIRR3), which rose 6.02% or 0.84 points to trade at 14.79 at the close. Meanwhile, Cury Constrtutora e Incorporadora S (BVMF:CURY3) added 4.25% or 1.47 points to end at 36.02 and C A Modas SA (BVMF:CEAB3) was up 3.94% or 0.47 points to 12.40 in late trade.

The worst performers of the session were Raizen SA Preferred (BVMF:RAIZ4), which fell 8.74% or 0.09 points to trade at 0.94 at the close. Petroreconcavo SA (BVMF:RECV3) declined 3.89% or 0.44 points to end at 10.86 and Brava Energia SA (BVMF:BRAV3) was down 3.92% or 0.74 points to 18.16.

Rising stocks outnumbered declining ones on the B3 Stock Exchange by 538 to 422 and 33 ended unchanged.

The CBOE Brazil Etf Volatility, which measures the implied volatility of Bovespa options, was up 3.38% to 32.38.

Gold Futures for April delivery was down 1.08% or 51.41 to $4,693.69 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in March fell 4.66% or 3.04 to hit $62.17 a barrel, while the March US coffee C contract rose 0.90% or 3.00 to trade at $335.25 .

USD/BRL was unchanged 0.00% to 5.26, while EUR/BRL fell 0.55% to 6.20.

The US Dollar Index Futures was up 0.68% at 97.52.

Investing.com -- Elong Power Holding Ltd (NASDAQ:ELPW) stock plunged 91.6% on Monday after the company announced the pricing of its underwritten public offering of 2.4 million units at $3.16 per unit.

The offering is expected to generate approximately $7.6 million in gross proceeds before deducting underwriting discounts and other expenses. Each unit consists of one Class A ordinary share (or one pre-funded warrant) and one common warrant to purchase an additional Class A ordinary share.

The common warrants will expire three years from issuance and are initially exercisable at $3.16 per share, but subject to adjustment on the 4th and 8th trading days following closing to 70% and 50% of the initial exercise price, respectively. Warrant holders may also exercise via a zero exercise price option to receive twice the number of shares without additional payment.

Elong Power, which provides high power battery technologies for commercial and specialty alternative energy vehicles and energy storage systems, plans to use the proceeds for general corporate purposes, sales network expansion, and production capacity enhancement.

Maxim Group LLC is serving as the exclusive underwriter for the offering, which is expected to close on February 3, 2026. The underwriters have a 45-day option to purchase up to an additional 360,000 Class A ordinary shares and/or 360,000 common warrants.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Pfizer Inc (NYSE:PFE) shares rose 0.2% to $26.49 on Monday as investors await the drugmaker’s quarterly earnings report scheduled for release before markets open on Tuesday.

Analysts expect Pfizer’s revenue to decrease approximately 5% to around $16.95 billion, while adjusted earnings per share are projected to fall 9.5% to 57 cents compared to 63 cents in the same period last year.

The pharmaceutical giant has a strong track record of meeting or exceeding expectations. Over the past eight quarters, Pfizer’s revenue has met analyst estimates six times, while its adjusted earnings per share has surpassed forecasts in every quarter during this period.

In December, Pfizer warned that the next few years would be challenging, starting with 2026. The company cited several factors for this outlook, including declining sales of its COVID-19 vaccine and treatment, price reductions promised to the U.S. government, and the expiration of patents on key medications. The drugmaker’s 2026 profit forecast fell below Wall Street expectations.

The Trump administration has recently negotiated agreements with Pfizer and other pharmaceutical companies to reduce the prices of their medicines for the government’s Medicaid program and for cash-paying customers.

Despite these challenges, Pfizer stock has gained approximately 6% year-to-date, outperforming the S&P 500 healthcare index, which has risen just 0.2% during the same period.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Wrap Technologies Inc (NASDAQ:WRAP) stock fell 7.1% Monday after the non-lethal response solutions provider announced a $5 million private placement to fund manufacturing restart and growth initiatives.

The company said it has entered into a securities purchase agreement to issue 2,500,000 shares of common stock at $2.00 per share, along with warrants to purchase an additional 2,500,000 shares at $2.30 per share. The private placement is expected to close around February 3, 2026, subject to customary closing conditions.

According to the company, the capital will enable Wrap to restart domestic manufacturing with improved quality control standards, advance research and development programs into commercialization, and accelerate growth initiatives aligned with increasing demand for non-lethal response capabilities.

"Our focus is on adding the resources required to accelerate growth, particularly across manufacturing, quality control, marketing, and R&D," said Scot Cohen, CEO of Wrap. "This capital may allow us to take proven concepts, finalize validation, and responsibly bring them to market, while restoring manufacturing excellence and expanding training to meet real operational demand."

The company is positioning itself beyond a single-device business model to become an integrated response platform combining technology, training, and policy. This strategic shift aims to expand Wrap’s addressable market across state, local, and federal agencies, as well as private-sector security environments.

Wrap is also increasing its domestic training capacity and focusing on bringing next-generation multi-shot systems and drone-enabled non-lethal delivery concepts to market. The company noted that many of its recent R&D initiatives have progressed through testing and are now entering final validation stages.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Argentina has purchased $808 million in drawing rights from the United States, according to recent financial data.

The transaction comes as broader Latin American markets showed mixed performance. The MSCI Latin American currencies index fell 0.3%, while regional stock markets remained subdued.

In other regional news, Chile’s January economic activity exceeded analyst forecasts, showing stronger-than-expected performance in the first month of the year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.